Literature DB >> 23218751

Deciphering the retinoblastoma protein phosphorylation code.

Seth M Rubin1.   

Abstract

Multisite phosphorylation modulates the function of regulatory proteins with complex signaling properties and outputs. The retinoblastoma tumor suppressor protein (Rb) is inactivated by cyclin-dependent kinase (Cdk) phosphorylation in normal and cancer cell cycles, so understanding the molecular mechanisms and effects of Rb phosphorylation is imperative. Rb functions in diverse processes regulating proliferation, and it has been speculated that multisite phosphorylation might act as a code in which discrete phosphorylations control specific activities. The idea of an Rb phosphorylation code is evaluated here in light of recent studies of Rb structure and function. Rb inactivation is discussed with an emphasis on how multisite phosphorylation changes Rb structure and associations with protein partners.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23218751      PMCID: PMC3529988          DOI: 10.1016/j.tibs.2012.10.007

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  80 in total

1.  Cumulative effect of phosphorylation of pRB on regulation of E2F activity.

Authors:  V D Brown; R A Phillips; B L Gallie
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

2.  The carboxyl-terminal region of the retinoblastoma protein binds non-competitively to protein phosphatase type 1alpha and inhibits catalytic activity.

Authors:  S Tamrakar; J W Ludlow
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

3.  Site-specific and temporally-regulated retinoblastoma protein dephosphorylation by protein phosphatase type 1.

Authors:  E Rubin; S Mittnacht; E Villa-Moruzzi; J W Ludlow
Journal:  Oncogene       Date:  2001-06-28       Impact factor: 9.867

Review 4.  Cyclin-dependent kinases: engines, clocks, and microprocessors.

Authors:  D O Morgan
Journal:  Annu Rev Cell Dev Biol       Date:  1997       Impact factor: 13.827

5.  A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein.

Authors:  W Pan; S Cox; R H Hoess; R H Grafström
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

6.  Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit.

Authors:  Ulrich K Binné; Marie K Classon; Frederick A Dick; Wenyi Wei; Michael Rape; William G Kaelin; Anders M Näär; Nicholas J Dyson
Journal:  Nat Cell Biol       Date:  2006-12-24       Impact factor: 28.824

7.  The retinoblastoma protein regulates pericentric heterochromatin.

Authors:  Christian E Isaac; Sarah M Francis; Alison L Martens; Lisa M Julian; Laurie A Seifried; Natalie Erdmann; Ulrich K Binné; Lea Harrington; Piotr Sicinski; Nathalie G Bérubé; Nicholas J Dyson; Frederick A Dick
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

Review 8.  Tailoring to RB: tumour suppressor status and therapeutic response.

Authors:  Erik S Knudsen; Karen E Knudsen
Journal:  Nat Rev Cancer       Date:  2008-09       Impact factor: 60.716

9.  p38 phosphorylates Rb on Ser567 by a novel, cell cycle-independent mechanism that triggers Rb-Hdm2 interaction and apoptosis.

Authors:  R B Delston; K A Matatall; Y Sun; M D Onken; J W Harbour
Journal:  Oncogene       Date:  2010-09-27       Impact factor: 9.867

10.  The retinoblastoma protein is phosphorylated on multiple sites by human cdc2.

Authors:  J A Lees; K J Buchkovich; D R Marshak; C W Anderson; E Harlow
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  109 in total

1.  The B″ regulatory subunit of protein phosphatase 2A mediates the dephosphorylation of rice retinoblastoma-related protein-1.

Authors:  Edit Ábrahám; Ping Yu; Ilona Farkas; Zsuzsanna Darula; Erzsébet Varga; Noémi Lukács; Ferhan Ayaydin; Katalin F Medzihradszky; Viktor Dombrádi; Dénes Dudits; Gábor V Horváth
Journal:  Plant Mol Biol       Date:  2014-11-15       Impact factor: 4.076

2.  Multisite light-induced phosphorylation of the transcription factor PIF3 is necessary for both its rapid degradation and concomitant negative feedback modulation of photoreceptor phyB levels in Arabidopsis.

Authors:  Weimin Ni; Shou-Ling Xu; Robert J Chalkley; Thao Nguyen D Pham; Shenheng Guan; Dave A Maltby; Alma L Burlingame; Zhi-Yong Wang; Peter H Quail
Journal:  Plant Cell       Date:  2013-07-31       Impact factor: 11.277

3.  An RB insensitive to CDK regulation.

Authors:  Manel Joaquin; Eulàlia de Nadal; Francesc Posas
Journal:  Mol Cell Oncol       Date:  2016-12-14

4.  Early and Late G1/S Cyclins and Cdks Act Complementarily to Enhance Authentic Human β-Cell Proliferation and Expansion.

Authors:  Shiwani Tiwari; Chris Roel; Rachel Wills; Gabriella Casinelli; Mansoor Tanwir; Karen K Takane; Nathalie M Fiaschi-Taesch
Journal:  Diabetes       Date:  2015-07-09       Impact factor: 9.461

5.  A Code of Mono-phosphorylation Modulates the Function of RB.

Authors:  Ioannis Sanidas; Robert Morris; Katerina A Fella; Purva H Rumde; Myriam Boukhali; Eric C Tai; David T Ting; Michael S Lawrence; Wilhelm Haas; Nicholas J Dyson
Journal:  Mol Cell       Date:  2019-01-30       Impact factor: 17.970

6.  Conservation and divergence of C-terminal domain structure in the retinoblastoma protein family.

Authors:  Tyler J Liban; Edgar M Medina; Sarvind Tripathi; Satyaki Sengupta; R William Henry; Nicolas E Buchler; Seth M Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

Review 7.  PP2A as a master regulator of the cell cycle.

Authors:  Nathan Wlodarchak; Yongna Xing
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-02-24       Impact factor: 8.250

8.  Role of Drosophila retinoblastoma protein instability element in cell growth and proliferation.

Authors:  Jared S Elenbaas; Rima Mouawad; R William Henry; David N Arnosti; Sandhya Payankaulam
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

9.  ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment.

Authors:  Hetal Patel; Manikandan Periyasamy; Georgina P Sava; Alexander Bondke; Brian W Slafer; Sebastian H B Kroll; Marion Barbazanges; Richard Starkey; Silvia Ottaviani; Alison Harrod; Eric O Aboagye; Laki Buluwela; Matthew J Fuchter; Anthony G M Barrett; R Charles Coombes; Simak Ali
Journal:  Mol Cancer Ther       Date:  2018-03-15       Impact factor: 6.261

10.  Structural Conservation and E2F Binding Specificity within the Retinoblastoma Pocket Protein Family.

Authors:  Tyler J Liban; Michael J Thwaites; Frederick A Dick; Seth M Rubin
Journal:  J Mol Biol       Date:  2016-08-25       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.